Rediscovering the Essence of ‘Health’ and ‘Care
In today’s fast-paced world, the essence of healthcare often gets lost in the shuffle. Johnson & Johnson, however, is on a mission to redefine the meaning behind two fundamental words:…
Read MoreRediscovering the Essence of ‘Health’ and ‘Care
Lilly Advises Shareholders to Decline Tutanota LLC’s ‘Mini-Tender’ Proposal
Eli Lilly and Company (NYSE: LLY) has received notification of an unsolicited “mini-tender” offer from Tutanota LLC (“Tutanota”), proposing to acquire up to 62,500 shares of Lilly common stock, which…
Bio-Techne and NovoMol-DX Unveil Point-of-Care Ocular Biomarker Test
Bio-Techne Corporation (NASDAQ: TECH) and Novomol-Dx, a pioneering molecular diagnostics firm, proudly introduce the Bio-Marker Pathfinder (BMP), a groundbreaking ocular biomarker kit designed for point-of-care application. Novomol-Dx specializes in commercializing…
Notice of Revisions to Dividend Forecasts (Dividend Increase)
Shionogi & Co., Ltd. (Headquartered in Osaka, Japan; CEO: Isao Teshirogi, Ph.D.; hereafter referred to as “Shionogi”) has announced revisions to its dividend forecasts for the fiscal year ending March…
BeiGene Showcases Worldwide Advancements in 2023 Corporate Responsibility & Sustainability Review
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a prominent global oncology firm, has unveiled its 2023 Responsible Business & Sustainability Report, spotlighting the company’s strategic direction, progress towards existing…
Rebuilding Trust and Steering Bayer Towards Enhanced Performance
Bayer Group’s divisions demonstrated resilience and strength in several core areas, surpassing industry peers, according to CEO Bill Anderson during the virtual Annual Stockholders’ Meeting. Anderson praised the progress in…
Moderna’s Showcase of Respiratory and Cytomegalovirus Research at the ESCMID Global Congress
Moderna, Inc. (NASDAQ: MRNA) has unveiled plans to share insights from its extensive respiratory portfolio, encompassing vaccines and vaccine candidates targeting COVID-19 (mRNA-1273, mRNA-1283), influenza (mRNA-1010, mRNA-1011/1012), and respiratory syncytial…
CHMP Grants Favorable Opinion to Biogen’s TOFIDENCE™ (tocilizumab), a Biosimilar of ROACTEMRA
Biogen Inc. (Nasdaq: BIIB) has announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a favorable opinion for TOFIDENCE™…
CHMP Recommends Fruquintinib for Previously Treated Metastatic Colorectal Cancer
Takeda has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the approval of fruquintinib, a selective inhibitor of vascular endothelial…
New Supervisory Board Elected at Merck’s Annual General Meeting
Merck, a prominent science and technology company, convened its 29th Annual General Meeting virtually today. With a significant majority, shareholders approved all items on the agenda, including the proposed dividend…
European Commission Grants Approval for KALYDECO® to Treat Cystic Fibrosis in Infants as Young as 1 Month Old, Announces Vertex
Vertex Pharmaceuticals (Nasdaq: VRTX) has received approval from the European Commission for the expansion of KALYDECO® (ivacaftor) labeling. This approval allows for the treatment of infants as young as 1…
FDA Grants Approval to Pfizer’s BEQVEZ™: A Single-Dose Gene Therapy for Hemophilia B in Adults
Today, Pfizer Inc. (NYSE: PFE) announced the approval of BEQVEZ™ (fidanacogene elaparvovec-dzkt) by the U.S. Food and Drug Administration (FDA) for the treatment of adults grappling with moderate to severe…